Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Non-Cystic Fibrosis Bronchiectasis Global Market Report 2025
Download Free Sample Buy Now
Global Non-Cystic Fibrosis Bronchiectasis Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Non-Cystic Fibrosis Bronchiectasis Global Market Report 2025

By Diagnosis (Computed Tomography (CT) Scan, Bronchoscopy, Chest X Ray, Lung Function, Sputum Culture Test, Blood Tests, Other Diagnosis Types), By Treatment (Surgery, Physiotherapy, Vaccination, Airway Pharmacotherapy, Antibiotics, Other Treatments), By End Use (Hospitals And Clinics, Ambulatory Care Centers, Other End Uses) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Non-Cystic Fibrosis Bronchiectasis Market Overview

• Non-Cystic Fibrosis Bronchiectasis market size has reached to $3.5 billion in 2024

• Expected to grow to $4.68 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%

• Growth Driver: Non-Cystic Fibrosis Bronchiectasis Market Thrives On Surging Respiratory Disease Cases

• Market Trend: Innovative Nebulization Solutions In Non-Cystic Fibrosis Bronchiectasis Treatment

• North America was the largest region in 2024.

What Is Covered Under Non-Cystic Fibrosis Bronchiectasis Market?

Non-cystic fibrosis bronchiectasis is a chronic condition characterized by permanent and abnormal widening of the airways (bronchi) in the lungs. This results from repeated inflammation and infection, leading to damage and weakening of the bronchial walls. It can cause mucus buildup, persistent coughing, breathlessness, and recurrent respiratory infections. Treatment often involves managing symptoms, preventing exacerbations, and addressing underlying causes such as bacterial infections or immune system dysfunction.

The main diagnosis types of non-cystic fibrosis bronchiectasis include computed tomography (CT) scans, bronchoscopies, chest X-rays, lung function, sputum culture tests, blood tests, and others. A CT scan provides detailed images of the lungs, helping to diagnose bronchiectasis by revealing the extent and location of lung damage. The treatment types are categorized into surgery, Physiotherapy, vaccination, airway pharmacotherapy, antibiotics, and others, and their end uses include hospitals and clinics, ambulatory care centers, and others.

Non-Cystic Fibrosis Bronchiectasis Market Size and growth rate 2025 to 2029: Graph

What Is The Non-Cystic Fibrosis Bronchiectasis Market Size 2025 And Growth Rate?

The non-cystic fibrosis bronchiectasis market size has grown strongly in recent years. It will grow from $3.5 billion in 2024 to $3.7 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to rising incidence and prevalence, advances in diagnostic technologies, growing geriatric population, government support and funding, improved healthcare infrastructure, increased diagnosis awareness, rising geriatric population, environmental exposure.

What Is The Non-Cystic Fibrosis Bronchiectasis Market Growth Forecast?

The non-cystic fibrosis bronchiectasis market size is expected to see strong growth in the next few years. It will grow to $4.68 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to advances in personalized medicine, the emergence of new biomarkers, increased investment in respiratory medicine, growing research and development, public health initiatives, the global aging population, and the development of targeted therapies. Major trends in the forecast period include digital health solutions, a focus on targeted therapies, the integration of AI and machine learning, a shift towards home-based care, patient-centric approaches, and the growth of mobile health (mHealth) solutions.

The forecast of 6.1% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of inhaled mucolytic therapies by inflating prices of nebulizers and dry powder inhalers developed in the Netherlands and Canada, resulting in reduced respiratory therapy adherence and higher pulmonology costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Non-Cystic Fibrosis Bronchiectasis Market Segmented?

1) By Diagnosis: Computed Tomography (CT) Scan, Bronchoscopy, Chest X Ray, Lung Function, Sputum Culture Test, Blood Tests, Other Diagnosis Types

2) By Treatment: Surgery, Physiotherapy, Vaccination, Airway Pharmacotherapy, Antibiotics, Other Treatments

3) By End Use: Hospitals And Clinics, Ambulatory Care Centers, Other End Uses

Subsegments:

1) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Standard CT

2) By Bronchoscopy: Flexible Bronchoscopy, Rigid Bronchoscopy

3) By Chest X-Ray: Standard Chest X-Ray, Digital Chest X-Ray

4) By Lung Function: Spirometry, Peak Flow Measurement

5) By Sputum Culture Test: Bacterial Culture, Fungal Culture, Viral Culture

6) By Blood Tests: Complete Blood Count (CBC), C-Reactive Protein (CRP), Immunoglobulin Levels

7) By Other Diagnosis Types: Sweat Test, Genetic Testing, Exhaled Nitric Oxide Test

What Is Driving The Non-Cystic Fibrosis Bronchiectasis Market? Non-Cystic Fibrosis Bronchiectasis Market Thrives On Surging Respiratory Disease Cases

The rising prevalence of respiratory diseases is expected to propel the growth of the non-cystic fibrosis bronchiectasis market going forward. Respiratory diseases encompass a range of conditions affecting the lungs and respiratory system, impacting breathing and overall respiratory function. The rising prevalence of respiratory diseases is primarily driven by increasing environmental pollution, including both outdoor pollutants and indoor irritants such as tobacco smoke. The increasing prevalence of respiratory infections presents opportunities for advancing understanding, diagnosis, and management of non-cystic fibrosis bronchiectasis through targeted interventions and public health efforts. For instance, in June 2023, according to a report published by the Office for Health Improvement and Disparities, a UK-based governmental body, a total of 4,622 notifications of scarlet fever Group A Streptococcus bacteria were received from week 37 to week 46 during the 2022-2023 season in England, with 851 notifications received in week 46 alone. This is significantly higher compared to an average of 1,294 notifications (ranging from 258 to 2,008) for the same period (weeks 37 to 46) over the previous five years. Therefore, the rising prevalence of respiratory diseases will drive the growth of the non-cystic fibrosis bronchiectasis industry.

Who Are The Major Players In The Global Non-Cystic Fibrosis Bronchiectasis Market?

Major companies operating in the non-cystic fibrosis bronchiectasis market are Pfizer Inc., F Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc (GSK), Boehringer Ingelheim International GmbH, Viatris Inc, Teva Pharmaceutical Industries Ltd, Vertex Pharmaceuticals, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd, Dr Reddy's Laboratories Ltd, Chiesi Farmaceutici SpA, Lupin Limited, Zambon Company SpA, Sunovion Pharmaceuticals Inc, Insmed Incorporated, Genentech, Zydus Cadila, Santhera Pharmaceuticals, TSRL Inc

What Are The Key Trends Of The Global Non-Cystic Fibrosis Bronchiectasis Market? Innovative Nebulization Solutions In Non-Cystic Fibrosis Bronchiectasis Treatment

Major companies operating in the non-cystic fibrosis bronchiectasis market are focusing on personalized medicine approaches, such as nebulization solutions, to optimize drug delivery efficiency and patient compliance. Nebulization solutions offer advanced technology for precise and effective delivery of respiratory medications, enhancing patient compliance and treatment outcomes. For instance, in April 2022, Zambon S.P.A, an Italy-based multinational pharmaceutical company, received a US FDA designation for CMS I-neb therapy in patients with non-cystic fibrosis bronchiectasis (NCFB). CMS I-net is an investigational treatment being developed as a potential first-in-class inhaled therapy for adult patients with NCFB colonized with P. aeruginosa. NCFB is a chronic, progressive, and irreversible respiratory disease. The breakthrough designation validates the registrational path for CMS I-neb in NCFB and facilitates potentially expedited development and review.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Non-Cystic Fibrosis Bronchiectasis Market? Chiesi Partners With Haisco To Commercialize Bronchiectasis Drug In China

In November 2023, Chiesi Farmaceutici SpA, an Italy-based pharmaceutical company, partnered with Haisco Pharmaceutical Group Co., Ltd. Through this partnership, Haisco will commercialize Chiesi's investigational bronchiectasis drug in China. This collaboration involves Haisco's financial and logistical support to facilitate the regulatory approval, marketing, and distribution efforts necessary for introducing the bronchiectasis drug to the Chinese market. Haisco Pharmaceutical Group Co. Ltd. is a China-based pharmaceutical company involved in the development of respiratory disease treatments such as bronchiectasis.

What Is The Regional Outlook For The Global Non-Cystic Fibrosis Bronchiectasis Market?

North America was the largest region in the non-cystic fibrosis bronchiectasis market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Non-Cystic Fibrosis Bronchiectasis Market?

The non-cystic fibrosis bronchiectasis market consists of revenues earned by entities by providing services such as diagnostic imaging, pulmonary function testing, medical consultations, home healthcare, pulmonary rehabilitation, and management of chronic respiratory infections through pharmaceutical treatments and advanced therapeutic technologies. The market value includes the value of related goods sold by the service provider or included within the service offering. The non-cystic fibrosis bronchiectasis market also includes sales of antibiotics, bronchodilators, mucolytics, inhalers, nebulizers, airway clearance devices, and respiratory monitoring devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Non-Cystic Fibrosis Bronchiectasis Industry?

The non-cystic fibrosis bronchiectasis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the non-cystic fibrosis bronchiectasis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Non-Cystic Fibrosis Bronchiectasis Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $3.7 billion
Revenue Forecast In 2034 $4.68 billion
Growth Rate CAGR of 6.1% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Diagnosis: Computed Tomography (CT) Scan, Bronchoscopy, Chest X Ray, Lung Function, Sputum Culture Test, Blood Tests, Other Diagnosis Types
2) By Treatment: Surgery, Physiotherapy, Vaccination, Airway Pharmacotherapy, Antibiotics, Other Treatments
3) By End Use: Hospitals And Clinics, Ambulatory Care Centers, Other End Uses Subsegments: 1) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Standard CT
2) By Bronchoscopy: Flexible Bronchoscopy, Rigid Bronchoscopy
3) By Chest X-Ray: Standard Chest X-Ray, Digital Chest X-Ray
4) By Lung Function: Spirometry, Peak Flow Measurement
5) By Sputum Culture Test: Bacterial Culture, Fungal Culture, Viral Culture 6) By Blood Tests: Complete Blood Count (CBC), C-Reactive Protein (CRP), Immunoglobulin Levels 7) By Other Diagnosis Types: Sweat Test, Genetic Testing, Exhaled Nitric Oxide Test
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., F Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc (GSK), Boehringer Ingelheim International GmbH, Viatris Inc, Teva Pharmaceutical Industries Ltd, Vertex Pharmaceuticals, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd, Dr Reddy's Laboratories Ltd, Chiesi Farmaceutici SpA, Lupin Limited, Zambon Company SpA, Sunovion Pharmaceuticals Inc, Insmed Incorporated, Genentech, Zydus Cadila, Santhera Pharmaceuticals, TSRL Inc
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Non-Cystic Fibrosis Bronchiectasis Market Characteristics

3. Non-Cystic Fibrosis Bronchiectasis Market Trends And Strategies

4. Non-Cystic Fibrosis Bronchiectasis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Non-Cystic Fibrosis Bronchiectasis Growth Analysis And Strategic Analysis Framework

5.1. Global Non-Cystic Fibrosis Bronchiectasis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Non-Cystic Fibrosis Bronchiectasis Market Growth Rate Analysis

5.4. Global Non-Cystic Fibrosis Bronchiectasis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Non-Cystic Fibrosis Bronchiectasis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Non-Cystic Fibrosis Bronchiectasis Total Addressable Market (TAM)

6. Non-Cystic Fibrosis Bronchiectasis Market Segmentation

6.1. Global Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Computed Tomography (CT) Scan

Bronchoscopy

Chest X Ray

Lung Function

Sputum Culture Test

Blood Tests

Other Diagnosis Types

6.2. Global Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Surgery

Physiotherapy

Vaccination

Airway Pharmacotherapy

Antibiotics

Other Treatments

6.3. Global Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Ambulatory Care Centers

Other End Uses

6.4. Global Non-Cystic Fibrosis Bronchiectasis Market, Sub-Segmentation Of Computed Tomography (CT) Scan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

High-Resolution CT (HRCT)

Standard CT

6.5. Global Non-Cystic Fibrosis Bronchiectasis Market, Sub-Segmentation Of Bronchoscopy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Flexible Bronchoscopy

Rigid Bronchoscopy

6.6. Global Non-Cystic Fibrosis Bronchiectasis Market, Sub-Segmentation Of Chest X-Ray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Standard Chest X-Ray

Digital Chest X-Ray

6.7. Global Non-Cystic Fibrosis Bronchiectasis Market, Sub-Segmentation Of Lung Function, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Spirometry

Peak Flow Measurement

6.8. Global Non-Cystic Fibrosis Bronchiectasis Market, Sub-Segmentation Of Sputum Culture Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bacterial Culture

Fungal Culture

Viral Culture

6.9. Global Non-Cystic Fibrosis Bronchiectasis Market, Sub-Segmentation Of Blood Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Complete Blood Count (CBC)

C-Reactive Protein (CRP)

Immunoglobulin Levels

6.10. Global Non-Cystic Fibrosis Bronchiectasis Market, Sub-Segmentation Of Other Diagnosis Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Sweat Test

Genetic Testing

Exhaled Nitric Oxide Test

7. Non-Cystic Fibrosis Bronchiectasis Market Regional And Country Analysis

7.1. Global Non-Cystic Fibrosis Bronchiectasis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Non-Cystic Fibrosis Bronchiectasis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market

8.1. Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Non-Cystic Fibrosis Bronchiectasis Market

9.1. China Non-Cystic Fibrosis Bronchiectasis Market Overview

9.2. China Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Non-Cystic Fibrosis Bronchiectasis Market

10.1. India Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Non-Cystic Fibrosis Bronchiectasis Market

11.1. Japan Non-Cystic Fibrosis Bronchiectasis Market Overview

11.2. Japan Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Non-Cystic Fibrosis Bronchiectasis Market

12.1. Australia Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Non-Cystic Fibrosis Bronchiectasis Market

13.1. Indonesia Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Non-Cystic Fibrosis Bronchiectasis Market

14.1. South Korea Non-Cystic Fibrosis Bronchiectasis Market Overview

14.2. South Korea Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Non-Cystic Fibrosis Bronchiectasis Market

15.1. Western Europe Non-Cystic Fibrosis Bronchiectasis Market Overview

15.2. Western Europe Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Non-Cystic Fibrosis Bronchiectasis Market

16.1. UK Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Non-Cystic Fibrosis Bronchiectasis Market

17.1. Germany Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Non-Cystic Fibrosis Bronchiectasis Market

18.1. France Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Non-Cystic Fibrosis Bronchiectasis Market

19.1. Italy Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Non-Cystic Fibrosis Bronchiectasis Market

20.1. Spain Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Non-Cystic Fibrosis Bronchiectasis Market

21.1. Eastern Europe Non-Cystic Fibrosis Bronchiectasis Market Overview

21.2. Eastern Europe Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Non-Cystic Fibrosis Bronchiectasis Market

22.1. Russia Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Non-Cystic Fibrosis Bronchiectasis Market

23.1. North America Non-Cystic Fibrosis Bronchiectasis Market Overview

23.2. North America Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Non-Cystic Fibrosis Bronchiectasis Market

24.1. USA Non-Cystic Fibrosis Bronchiectasis Market Overview

24.2. USA Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Non-Cystic Fibrosis Bronchiectasis Market

25.1. Canada Non-Cystic Fibrosis Bronchiectasis Market Overview

25.2. Canada Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Non-Cystic Fibrosis Bronchiectasis Market

26.1. South America Non-Cystic Fibrosis Bronchiectasis Market Overview

26.2. South America Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Non-Cystic Fibrosis Bronchiectasis Market

27.1. Brazil Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Non-Cystic Fibrosis Bronchiectasis Market

28.1. Middle East Non-Cystic Fibrosis Bronchiectasis Market Overview

28.2. Middle East Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Non-Cystic Fibrosis Bronchiectasis Market

29.1. Africa Non-Cystic Fibrosis Bronchiectasis Market Overview

29.2. Africa Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Non-Cystic Fibrosis Bronchiectasis Market Competitive Landscape And Company Profiles

30.1. Non-Cystic Fibrosis Bronchiectasis Market Competitive Landscape

30.2. Non-Cystic Fibrosis Bronchiectasis Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

31. Non-Cystic Fibrosis Bronchiectasis Market Other Major And Innovative Companies

31.1. Bristol-Myers Squibb Company

31.2. AstraZeneca plc

31.3. Abbott Laboratories

31.4. Novartis AG

31.5. GlaxoSmithKline plc (GSK)

31.6. Boehringer Ingelheim International GmbH

31.7. Viatris Inc.

31.8. Teva Pharmaceutical Industries Ltd.

31.9. Vertex Pharmaceuticals

31.10. Sun Pharmaceutical Industries Ltd.

31.11. Aurobindo Pharma Ltd.

31.12. Dr. Reddy's Laboratories Ltd.

31.13. Chiesi Farmaceutici SpA

31.14. Lupin Limited

31.15. Zambon Company SpA

32. Global Non-Cystic Fibrosis Bronchiectasis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Non-Cystic Fibrosis Bronchiectasis Market

34. Recent Developments In The Non-Cystic Fibrosis Bronchiectasis Market

35. Non-Cystic Fibrosis Bronchiectasis Market High Potential Countries, Segments and Strategies

35.1 Non-Cystic Fibrosis Bronchiectasis Market In 2029 - Countries Offering Most New Opportunities

35.2 Non-Cystic Fibrosis Bronchiectasis Market In 2029 - Segments Offering Most New Opportunities

35.3 Non-Cystic Fibrosis Bronchiectasis Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Non-Cystic Fibrosis Bronchiectasis Market, Sub-Segmentation Of Computed Tomography (CT) Scan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Non-Cystic Fibrosis Bronchiectasis Market, Sub-Segmentation Of Bronchoscopy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Non-Cystic Fibrosis Bronchiectasis Market, Sub-Segmentation Of Chest X-Ray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Non-Cystic Fibrosis Bronchiectasis Market, Sub-Segmentation Of Lung Function, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Non-Cystic Fibrosis Bronchiectasis Market, Sub-Segmentation Of Sputum Culture Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Non-Cystic Fibrosis Bronchiectasis Market, Sub-Segmentation Of Blood Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Non-Cystic Fibrosis Bronchiectasis Market, Sub-Segmentation Of Other Diagnosis Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Non-Cystic Fibrosis Bronchiectasis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Non-Cystic Fibrosis Bronchiectasis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Pfizer Inc. Financial Performance
  • Table 82: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 83: Merck & Co. Inc. Financial Performance
  • Table 84: Bayer AG Financial Performance
  • Table 85: Sanofi SA Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Non-Cystic Fibrosis Bronchiectasis Market, Sub-Segmentation Of Computed Tomography (CT) Scan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Non-Cystic Fibrosis Bronchiectasis Market, Sub-Segmentation Of Bronchoscopy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Non-Cystic Fibrosis Bronchiectasis Market, Sub-Segmentation Of Chest X-Ray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Non-Cystic Fibrosis Bronchiectasis Market, Sub-Segmentation Of Lung Function, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Non-Cystic Fibrosis Bronchiectasis Market, Sub-Segmentation Of Sputum Culture Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Non-Cystic Fibrosis Bronchiectasis Market, Sub-Segmentation Of Blood Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Non-Cystic Fibrosis Bronchiectasis Market, Sub-Segmentation Of Other Diagnosis Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Non-Cystic Fibrosis Bronchiectasis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Non-Cystic Fibrosis Bronchiectasis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Non-Cystic Fibrosis Bronchiectasis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Pfizer Inc. Financial Performance
  • Figure 82: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 83: Merck & Co. Inc. Financial Performance
  • Figure 84: Bayer AG Financial Performance
  • Figure 85: Sanofi SA Financial Performance

Emerging Trends and Growth Drivers in the Pediatric Dental Market Through 2029

Read More About Emerging Trends and Growth Drivers in the Pediatric Dental Market Through 2029

Competitive and Market Trend Analysis of Pharmaceutical Cold Chain Packaging Industry Through 2029

Read More About Competitive and Market Trend Analysis of Pharmaceutical Cold Chain Packaging Industry Through 2029

Key Market Drivers, Trends, and Forecast for the Global Pharmaceutical Warehousing Industry

Read More About Key Market Drivers, Trends, and Forecast for the Global Pharmaceutical Warehousing Industry

2025 Analysis: Opportunities and Risks in the Evolving Precision Genomic Testing Market

Read More About 2025 Analysis: Opportunities and Risks in the Evolving Precision Genomic Testing Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Non-Cystic Fibrosis Bronchiectasis Global Market Report 2025 – By Diagnosis (Computed Tomography (CT) Scan, Bronchoscopy, Chest X Ray, Lung Function, Sputum Culture Test, Blood Tests, Other Diagnosis Types), By Treatment...

View Report

Idiopathic Pulmonary Fibrosis Global Market Report 2025 – By Drug Type (Nintedanib, Pirfenidone, Other Drug Types), By Mode Of Action (Antifibrotic Agents, Tyrosine Kinase Inhibitors, Other Modes of Action), By Route Of ...

View Report

Cystic Fibrosis (CF) Therapeutics Global Market Report 2025 – By Drug Class (Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, CFTR Modulators), By Route Of Administration (Oral, Inhaled), By Treatment Method (M...

View Report

Bronchoscope Global Market Report 2025 – By Type (Rigid Bronchoscopes, Flexible Bronchoscopes), By Usability (Reusable Bronchoscopes, Disposable Bronchoscopes), By Application (Diagnosis, Treatments), By End User (Hospit...

View Report

Bronchodilators Global Market Report 2025 – By Type (Beta-Adrenergic Bronchodilators, Anticholinergic Bronchodilators, Xanthine Derivatives, Other Types), By Route of Administration (Oral, Nasal (Inhalation), Injectable)...

View Report

Bronchitis Treatment Global Market Report 2025 – By Type (Acute Bronchitis, Chronic Bronchitis), By Treatment (Drugs, Oxygen Therapy), By Distribution Channel (Online Pharmaceutical Stores, Retail Pharmacies, Hospital Ph...

View Report

Bronchodilators Global Market Report 2025 – By Type (Beta-Adrenergic Bronchodilators, Anticholinergic Bronchodilators, Xanthine Derivatives, Other Types), By Route of Administration (Oral, Nasal (Inhalation), Injectable)...

View Report

Interstitial Lung Disease Global Market Report 2025 – By Drug Type (Oral Corticosteroids, Immune Suppressing, Anti-Fibrotic Medication, Other Drugs), By Disease Type (Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis...

View Report

Frequently Asked Questions

Non-cystic fibrosis bronchiectasis is a chronic condition characterized by permanent and abnormal widening of the airways (bronchi) in the lungs. This results from repeated inflammation and infection, leading to damage and weakening of the bronchial walls. It can cause mucus buildup, persistent coughing, breathlessness, and recurrent respiratory infections. Treatment often involves managing symptoms, preventing exacerbations, and addressing underlying causes such as bacterial infections or immune system dysfunction. For further insights on this market, request a sample here

The market major growth driver - Non-Cystic Fibrosis Bronchiectasis Market Thrives On Surging Respiratory Disease Cases. For further insights on this market, request a sample here

The non-cystic fibrosis bronchiectasis market size has grown strongly in recent years. It will grow from $3.5 billion in 2024 to $3.7 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to rising incidence and prevalence, advances in diagnostic technologies, growing geriatric population, government support and funding, improved healthcare infrastructure, increased diagnosis awareness, rising geriatric population, environmental exposure. The non-cystic fibrosis bronchiectasis market size is expected to see strong growth in the next few years. It will grow to " $4.68 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to advances in personalized medicine, the emergence of new biomarkers, increased investment in respiratory medicine, growing research and development, public health initiatives, the global aging population, and the development of targeted therapies. Major trends in the forecast period include digital health solutions, a focus on targeted therapies, the integration of AI and machine learning, a shift towards home-based care, patient-centric approaches, and the growth of mobile health (mHealth) solutions. For further insights on this market, request a sample here

The non-cystic fibrosis bronchiectasismarket covered in this report is segmented –
1) By Diagnosis: Computed Tomography (CT) Scan; Bronchoscopy; Chest X Ray; Lung Function; Sputum Culture Test; Blood Tests; Other Diagnosis Types
2) By Treatment: Surgery; Physiotherapy; Vaccination; Airway Pharmacotherapy; Antibiotics; Other Treatments
3) By End Use: Hospitals And Clinics; Ambulatory Care Centers; Other End Uses Subsegments:
1) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT); Standard CT
2) By Bronchoscopy: Flexible Bronchoscopy; Rigid Bronchoscopy
3) By Chest X-Ray: Standard Chest X-Ray; Digital Chest X-Ray
4) By Lung Function: Spirometry; Peak Flow Measurement
5) By Sputum Culture Test: Bacterial Culture; Fungal Culture; Viral Culture
6) By Blood Tests: Complete Blood Count (CBC); C-Reactive Protein (CRP); Immunoglobulin Levels
7) By Other Diagnosis Types: Sweat Test; Genetic Testing; Exhaled Nitric Oxide Test For further insights on this market, request a sample here

North America was the largest region in the non-cystic fibrosis bronchiectasis market in 2024. The regions covered in the non-cystic fibrosis bronchiectasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the non-cystic fibrosis bronchiectasis market are Pfizer Inc., F Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc (GSK), Boehringer Ingelheim International GmbH, Viatris Inc, Teva Pharmaceutical Industries Ltd, Vertex Pharmaceuticals, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd, Dr Reddy's Laboratories Ltd, Chiesi Farmaceutici SpA, Lupin Limited, Zambon Company SpA, Sunovion Pharmaceuticals Inc, Insmed Incorporated, Genentech, Zydus Cadila, Santhera Pharmaceuticals, TSRL Inc. For further insights on this market, request a sample here.

Major trends in this market include Innovative Nebulization Solutions In Non-Cystic Fibrosis Bronchiectasis Treatment. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Non-Cystic Fibrosis Bronchiectasis Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon